Plimasine
Brand names,
Plimasine
Analogs
Plimasine
Brand Names Mixture
Plimasine
Chemical_Formula
C14H19NO2
Plimasine
RX_link
http://www.rxlist.com/cgi/generic/methphen.htm
Plimasine
fda sheet
Plimasine
msds (material safety sheet)
Plimasine
Synthesis Reference
M. Hartmann, L. Panizzon, U.S. Pat. 2,507,631 (1950)
Plimasine
Molecular Weight
233.306 g/mol
Plimasine
Melting Point
224-226oC
Plimasine
H2O Solubility
1255mg/L
Plimasine
State
Solid
Plimasine
LogP
3.192
Plimasine
Dosage Forms
Tablets; Tablets (sustained release)
Plimasine
Indication
For use as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity.
Plimasine
Pharmacology
Methylphenidate is a central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Its mechanisms appear to be similar to those of dextroamphetamine.
Plimasine
Absorption
Readily absorbed in a biphasic manner. It reaches peak absorption at approximately two hours for the first phase and five hours for the second phase. Bioavailability is low (approximately 30%)
Plimasine
side effects and Toxicity
Symptoms of overdose include vomiting, agitation, tremors, hyperreflexia, muscle twitching, convulsions (may be followed by coma), euphoria, confusion, hallucinations, delirium, sweating, flushing, headache, hyperpyrexia, tachycardia, palpitations, cardiac arrhythmias, hypertension, mydriasis, and dryness of mucous membranes. LD50=190mg/kg (orally in mice)
Plimasine
Patient Information
Plimasine
Organisms Affected
Humans and other mammals